CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 91 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 3.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $188,000 | -53.2% | 16,761 | -43.0% | 0.05% | -52.8% |
Q1 2016 | $402,000 | -28.0% | 29,400 | 0.0% | 0.11% | -27.5% |
Q4 2015 | $558,000 | +62.7% | 29,400 | +60.7% | 0.15% | +104.1% |
Q3 2015 | $343,000 | +34200.0% | 18,300 | +13976.9% | 0.07% | – |
Q2 2014 | $1,000 | – | 130 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |